Skip to main content

The Value of Evaluation

Independent Valuations

Talking to people in the front office dealing with OTC derivatives, they occasionally seem puzzled that a data vendor would have the expertise to put a price tag to one of their highly complex instruments. "It is impossible for a vendor to price a CLO," one broker said, remarking that I obviously did not understand the complexity of such instruments when appearing to be in support of taking prices from independent service providers for illiquid instruments.

And with recent development in the

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: https://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

The market’s most valuable asset?

DTCC’s Tim Lind writes that using data effectively can provide the intelligence needed to improve investment performance, reduce risk, and inform strategic decision‑making.

Navigating the MarketAxess ICE storm

The Waters Wrap: Most of the discussion surrounding ICE’s MarketAxess buy has focused more on benefits for the front office than the data possibilities.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here